Synthetic DNA of Unlimited Length

Delivered in days. Accurate and affordable.

Ribbon Biolabs is developing a revolutionary technology for the fast and efficient automated synthesis of DNA to enable the new wave of biotechnological innovation.

Through our unique technology combining biochemistry, computing and automation, Ribbon Biolabs will make complex DNA accessible and affordable for our customers in the biotech industry and in academia. 

Ribbon Biolabs wants to place itself as the key player in synthetic DNA of any complexity, empowering its customers to tackle challenges and develop products  that today are only possible in our imagination.

Accelerate your R&D

We make synthetic DNA of any length available for your innovative application in biotechnology, biopharma or academic research. Wether you need long DNA molecules or variant libraries – with our radically novel technology, you will have it at hand in only days and at affordable cost.

Invest in the future of biotech

Synthetic biology is not only one of the most rapidly growing markets, it also has disruptive potential. The major bottleneck for its advance is the availability of  synthetic DNA. Ribbon Biolabs’ cost-efficient platform for automated high-throughput production of long and complex DNA molecules will help to overcome this impediment.

Invest in the future of biotech

Synthetic biology is one of the most rapidly growing markets and has disruptive potential for many industries. The major bottleneck for its advance is the availability of synthetic DNA. Ribbon Biolabs’ platform for automated high-throughput production of long DNA will help to overcome this impediment.

.

Join our team

As an early-stage startup company with ambitious growth plans we are always looking for talented people to expand our diverse and interdisciplinary team. Besides a workplace in one of the most liveable cities of the world and a new state-of-the art laboratory we offer the opportunity to grow with the company.

News and Events

Sep 11, 2020

Meet us (virtually) at the 12th Annual ÖGMBT Meeting

Meet us on September 23 at the Life Science Career Fair! The Annual ÖGMBT Meeting is the melting pot of the Austrian Life Science Community …

Jun 6, 2020 

Funding the future: The race for a vaccine

Ribbon Biolabs’ CEO is discussing the funds required to develop a coronavirus vaccine in an online special event organized by the online magazine Metropole …

Apr 12, 2019

Ribbon Biolabs is ‘Startup of the Week’ in labiotech.eu

We are honored to be featured on labiotech.eu as ‘Startup of the Week’. Thanks to Jonathan Smith for the comprehensive article …

Twitter Feed

Ribbon Biolabs is seeking a "Computational Biology Developer" to contribute to the company's technology through the advancement of the algorithmic core of its proprietary DNA synthesis platform. Join us in taking synthetic biology to the next level! 🧬
https://ribbonbiolabs.com/career/

Ribbon Biolabs is seeking a "Computational Biology Developer" to contribute to the company's technology through the advancement of the algorithmic core of its proprietary DNA synthesis platform. Join us in taking synthetic biology to the next level! 🧬
https://ribbonbiolabs.com/career/

BREAKING NEWS:
The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing.”

BREAKING NEWS:
The 2020 #NobelPrize in Physiology or Medicine has been awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice “for the discovery of Hepatitis C virus.”

Load More...